Posted By:
NatureMed
Category:
Integrative Cancer Support
Extracorporeal photopheresis (ECP) is a type of ultraviolet blood irradiation that is being studies extensively right now for a variety of conditions such as cancer, infections, pain and inflammation. As we noted earlier we are enrolling patients in a study on this treatment. STUDY: Photodermatol Photoimmunol Photomed. 2015 Jul;31(4):184-94. doi: 10.1111/phpp.12175. Epub 2015 Mar 28. The effect of extracorporeal photopheresis alone or in combination therapy on circulating CD4(+) Foxp3(+) CD25(-) T cells in patients with leukemic cutaneous T-cell lymphoma. Shiue LH(1,)(2), Couturier J(3,)(4), Lewis DE(3,)(4), Wei C(5), Ni X(1,)(2), Duvic M(1,)(2). Author information: (1)Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (2)Graduate Program in Immunology, Graduate School of Biomedical Sciences, University of Texas Health Science Center at Houston, Houston, TX, USA. (3)Department of Internal Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA. (4)Graduate Program in Virology, Graduate School of Biomedical Sciences, University of Texas Health Science Center at Houston, Houston, TX, USA. (5)Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. PURPOSE: Extracorporeal photopheresis (ECP) alone or in combination therapy is effective for treatment of leukemic cutaneous T-cell lymphoma (L-CTCL), but its mechanism(s) of action remain...